Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for ...
Yale Led Study's Findings Consistent with Multiple European Trials - Post Procedure MRI Reveals New Brain Lesions in 94% of TAVR Patients The primary findings of the study were consistent with prior ...
MedPage Today on MSN
JenaValve TAVR device promising for LVAD-associated aortic regurgitation
Good results reported with emergency-use and compassionate-use cases ...
Perhaps due to the increase in transcatheter valve-in-valve cases, repeat surgery for a failed bioprosthetic valve has been declining in recent years and newer data has shown better outcomes with the ...
WASHINGTON, DC — Transcatheter aortic valve replacement (TAVR) is superior to surveillance in patients with severe but asymptomatic aortic stenosis with no apparent cost in adverse events, according ...
The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly ...
The novel findings, published today in the peer-reviewed journal The Lancet, are significant because recent randomized clinical trials have shown that TAVR is a meaningful treatment option for both ...
Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...
SAN FRANCISCO -- Better indicators of high-grade atrioventricular (AV) conduction system abnormalities following transcatheter aortic valve replacement (TAVR) could be gleaned from an intraprocedural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results